Salomon M Stemmer
Biographic Data
| ID | 7809106 |
|---|---|
| NAME | Salomon M Stemmer |
| GIVEN NAMES | Salomon M |
| FAMILY NAME | Stemmer |
| SIGNATURE | STEMMER S M |
| AFFILIATIONS | Rabin Medical Center |
| ORCID | 0000-0002-8733-3929 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Why Is End-of-Life Spending So High? Evidence from Cancer Patients
We study the sources of high end-of-life spending for cancer patients. Even among patients with similar initial prognoses, spending in the year postdiagnosis is over twice as high for those who die within the year than those who survive. Elevated spending on decedents is predominantly driven by higher inpatient spending, particularly low-intensity admissions. However, most such admissions do not result in death, making it difficult to target spen…
Stability and transitions in posttraumatic growth trajectories among cancer patients
The majority of transitions between different adaptation profiles occurred between 6 and 12 months after treatment. These findings offer theoretical and practice implications regarding posttraumatic growth in breast-cancer patients by distinguishing between profiles of adaptation and highlights a previously unidentified profile-struggling growth. These results contribute to the theoretical understanding of the complex relationship between growth,…
No prominent works on this page.
Stability and transitions in posttraumatic growth trajectories among cancer patients
The majority of transitions between different adaptation profiles occurred between 6 and 12 months after treatment. These findings offer theoretical and practice implications regarding posttraumatic growth in breast-cancer patients by distinguishing between profiles of adaptation and highlights a previously unidentified profile-struggling growth. These results contribute to the theoretical understanding of the complex relationship between growth,…
Why Is End-of-Life Spending So High? Evidence from Cancer Patients
We study the sources of high end-of-life spending for cancer patients. Even among patients with similar initial prognoses, spending in the year postdiagnosis is over twice as high for those who die within the year than those who survive. Elevated spending on decedents is predominantly driven by higher inpatient spending, particularly low-intensity admissions. However, most such admissions do not result in death, making it difficult to target spen…
Cancer (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Adaptation (eye (1 work) · Biology (1 work) · Breast cancer (1 work) · Cancer survivorship and care (1 work) · Childhood Cancer Survivors' Quality of Life (1 work) · Clinical Psychology (1 work) · Clinical Psychology (1 work)